These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16855347)

  • 21. Fondaparinux: does it cause HIT? Can it treat HIT?
    Warkentin TE
    Expert Rev Hematol; 2010 Oct; 3(5):567-81. PubMed ID: 21083474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia.
    Denys B; Stove V; Philippé J; Devreese K
    Thromb Res; 2008; 123(1):137-45. PubMed ID: 18582919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
    Dellaria SM; Greilich PE; Sarode R
    Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
    Fretschner R; Dietrich K; Unertl K; Greinacher A
    Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current insights into the laboratory diagnosis of HIT.
    Bakchoul T; Zöllner H; Greinacher A
    Int J Lab Hematol; 2014 Jun; 36(3):296-305. PubMed ID: 24750676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
    Selleng K; Warkentin TE; Sheppard JA; Greinacher A
    Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etiology and assessment of hypercoagulability with lessons from heparin-induced thrombocytopenia.
    Sniecinski RM; Hursting MJ; Paidas MJ; Levy JH
    Anesth Analg; 2011 Jan; 112(1):46-58. PubMed ID: 21081779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of a new, rapid, automated immunoassay for the detection of anti-platelet factor 4/heparin complex antibodies.
    Davidson SJ; Ortel TL; Smith LJ
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):340-4. PubMed ID: 21415710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia: frequency and pathogenesis.
    Greinacher A
    Pathophysiol Haemost Thromb; 2006; 35(1-2):37-45. PubMed ID: 16855345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.
    Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M
    Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.
    Radaideh SM; Frenkel EP; Dowell JE; Sarode R; Shen YM
    Clin Appl Thromb Hemost; 2012; 18(2):215-7. PubMed ID: 22067544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heparin induced thrombocytopenia].
    Brenske M; Tarnow J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jul; 33(7):411-6. PubMed ID: 9728258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
    Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
    J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?
    Warkentin TE; Sheppard JA; Moore JC; Moore KM; Sigouin CS; Kelton JG
    J Lab Clin Med; 2005 Dec; 146(6):341-6. PubMed ID: 16310517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
    Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A
    Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.